Literature DB >> 1540760

The Hamilton scales and the Hopkins Symptom Checklist (SCL-90). A cross-national validity study in patients with panic disorders.

P Bech1, P Allerup, W Maier, M Albus, P Lavori, J L Ayuso.   

Abstract

The HRSD, HRSA, SCL-90 scales were psychometrically investigated in a cross-national sample of patients with varieties of non-psychotic symptoms of anxiety and depression. Across the cultural backgrounds the scores obtained from the original versions of these scales are not sufficient statistics. However, latent structure analysis has identified homogeneous subscales for depression (the HRSD) and for discomfort (an SCL subscale). High concurrent validity was found between the subscales of depression, anxiety and discomfort. In international research, inhomogeneity among scale items can be confounded with group differences which are usually ascribed to drug differences.

Entities:  

Mesh:

Year:  1992        PMID: 1540760     DOI: 10.1192/bjp.160.2.206

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  15 in total

1.  The role of negative affectivity and negative reactivity to emotions in predicting outcomes in the unified protocol for the transdiagnostic treatment of emotional disorders.

Authors:  Shannon Sauer-Zavala; James F Boswell; Matthew W Gallagher; Kate H Bentley; Amantia Ametaj; David H Barlow
Journal:  Behav Res Ther       Date:  2012-06-09

2.  Relationship between job dissatisfaction and physical and psychological health among Filipino immigrants.

Authors:  A B de Castro; Gilbert C Gee; David Takeuchi
Journal:  AAOHN J       Date:  2008-01

3.  The Impact of the Unified Protocol for Emotional Disorders on Quality of Life.

Authors:  Matthew W Gallagher; Shannon E Sauer-Zavala; James F Boswell; Jenna R Carl; Jackie Bullis; Todd J Farchione; David H Barlow
Journal:  Int J Cogn Ther       Date:  2013-03-01

Review 4.  Quality-of-Life measurements for patients taking which drugs? The clinical PCASEE perspective.

Authors:  P Bech
Journal:  Pharmacoeconomics       Date:  1995-02       Impact factor: 4.981

5.  Readiness to change as a moderator of outcome in transdiagnostic treatment.

Authors:  James F Boswell; Shannon E Sauer-Zavala; Matthew W Gallagher; Nicole K Delgado; David H Barlow
Journal:  Psychother Res       Date:  2012-05-21

6.  The Montgomery Asberg and the Hamilton ratings of depression: a comparison of measures.

Authors:  Thomas J Carmody; A John Rush; Ira Bernstein; Diane Warden; Stephen Brannan; Daniel Burnham; Ada Woo; Madhukar H Trivedi
Journal:  Eur Neuropsychopharmacol       Date:  2006-06-12       Impact factor: 4.600

7.  A randomized double-blind placebo-controlled study of tropisetron in the treatment of outpatients with generalized anxiety disorder.

Authors:  Y Lecrubier; A J Puech; A Azcona; P E Bailey; X Lataste
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Intolerance of uncertainty: a common factor in the treatment of emotional disorders.

Authors:  James F Boswell; Johanna Thompson-Hollands; Todd J Farchione; David H Barlow
Journal:  J Clin Psychol       Date:  2013-02-04

9.  Symptoms of posttraumatic stress disorder after ritual female genital surgery among bedouin in Israel: myth or reality?

Authors:  Julia Applebaum; Hagit Cohen; Michael Matar; Yones Abu Rabia; Zeev Kaplan
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

10.  Treating depressive disorders with the Unified Protocol: A preliminary randomized evaluation.

Authors:  Shannon Sauer-Zavala; Kate H Bentley; Stephanie Jarvi Steele; Julianne Wilner Tirpak; Amantia A Ametaj; Maya Nauphal; Nicole Cardona; Mengxing Wang; Todd J Farchione; David H Barlow
Journal:  J Affect Disord       Date:  2019-11-13       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.